Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cook, J. A.
Right arrow Articles by Normansell, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cook, J. A.
Right arrow Articles by Normansell, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In a Neonate with Down Syndrome

Immunophenotypic Studies

James A. Cook, MD

Division of Pediatric Hematology-Oncology and the Department of Pediatrics, University of Virginia Medical Center

Beverly Raney, JR, MD

Division of Pediatric Hematology-Oncology and the Department of Pediatrics, University of Virginia Medical Center

Donald J. Innes, JR, MD

Division of Hematopathology and The Department of Pathology, University of Virginia Medical Center, Charlottesville, Virginia

David Normansell, PhD

Division of Hematopathology and The Department of Pathology, University of Virginia Medical Center, Charlottesville, Virginia

This report describes the results of bone marrow leukocyte immunophenotypic studies, DNA index measurement, and chromosome analysis in a newborn with Down syndrome and transient myeloproliferative disorder. The infant's initial leukocytosis with immature cells in the peripheral blood and thrombocytopenia resolved without treatment by 6 months of age, and he was well at 2 years of age. The lack of specific reactivity between the patient's morphologically immature cells and multiple monoclonal antibodies directed against lymphoid and myeloid leukemia cells may be characteristic of this disorder. Other cases should be examined for immunophenotype to correlate the results with chromosomal analysis and to provide a basis for comparison in those who subsequently develop true acute leukemia.

Clinical Pediatrics, Vol. 28, No. 3, 132-135 (1989)
DOI: 10.1177/000992288902800306


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
CLIN PEDIATRHome page
A. Dave, J. Ramet, B. Hauser, E. Schmedding, G. Amendola, L. Amato, G. Cirillo, G. Dante, F. J. DiMario, C. M. Chee, et al.
Letters to the Editor
Clinical Pediatrics, August 1, 1990; 29(8): 485 - 487.
[PDF]